BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35946134)

  • 1. Role of Long Noncoding RNA Regulator of Reprogramming in Colon Cancer Progression via Epidermal Growth Factor Receptor Signaling.
    Chen Y; Yang L; Yin D; Feng X; Jie J; Yao D; Chen J
    Technol Cancer Res Treat; 2022; 21():15330338221114707. PubMed ID: 35946134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
    Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
    Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
    [No Abstract]   [Full Text] [Related]  

  • 3. Linc-RoR promotes proliferation, migration, and invasion via the Hippo/YAP pathway in pancreatic cancer cells.
    Chen W; Wang H; Liu Y; Xu W; Ling C; Li Y; Liu J; Chen M; Zhang Y; Chen B; Gong A; Xu M
    J Cell Biochem; 2020 Jan; 121(1):632-641. PubMed ID: 31452251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linc-ROR inhibits NK cell-killing activity by promoting RXRA ubiquitination and reducing MICB expression in gastric cancer patients.
    Niu Q; Li Z; Jiang H; Hu B
    J Cell Biochem; 2024 Feb; 125(2):e30516. PubMed ID: 38205878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX2-Induced Linc-ROR Upregulation Inhibits Gastric Carcinoma Cell Proliferation and Metastasis Via the miR-580-3p/ANXA10 Pathway.
    Bai L; Zhuang Y; Xie J; Liu K; Yin S; Yan F
    Biochem Genet; 2023 Jun; 61(3):1113-1127. PubMed ID: 36451051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of hypoxia-signaling pathways by extracellular linc-RoR.
    Takahashi K; Yan IK; Haga H; Patel T
    J Cell Sci; 2014 Apr; 127(Pt 7):1585-94. PubMed ID: 24463816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2.
    Gao H; Wang T; Zhang P; Shang M; Gao Z; Yang F; Liu R
    J Cell Physiol; 2020 Mar; 235(3):2325-2335. PubMed ID: 31541467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc-ROR targets FGF2 to regulate HASMC proliferation and migration via sponging miR-195-5p.
    Ji Z; Chi J; Sun H; Ru A; Ni T; Zhang J; Jiang F; Lv H; Peng F; Guo H; Chen Y
    Gene; 2020 Jan; 725():144143. PubMed ID: 31629816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linc-ROR promotes invasion and metastasis of gastric cancer by activating epithelial-mesenchymal transition.
    Liu M; Zhang M; Yin H
    Indian J Pathol Microbiol; 2022; 65(3):545-550. PubMed ID: 35900480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
    Peng WX; Huang JG; Yang L; Gong AH; Mo YY
    Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
    Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
    Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
    Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
    Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functions of long non-coding RNA ROR in patient-derived glioblastoma cells.
    Kovalenko TF; Yadav B; Anufrieva KS; Rubtsov YP; Zatsepin TS; Shcherbinina EY; Solyus EM; Staroverov DB; Larionova TD; Latyshev YA; Shakhparonov MI; Pandey AK; Pavlyukov MS
    Biochimie; 2022 Sep; 200():131-139. PubMed ID: 35654242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma.
    Toraih EA; El-Wazir A; Hussein MH; Khashana MS; Matter A; Fawzy MS; Hosny S
    Int J Biol Markers; 2019 Mar; 34(1):69-79. PubMed ID: 30852975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linc-ROR promotes the progression of breast cancer and decreases the sensitivity to rapamycin through miR-194-3p targeting MECP2.
    Zhou Q; Guo J; Huang W; Yu X; Xu C; Long X
    Mol Oncol; 2020 Sep; 14(9):2231-2250. PubMed ID: 32335998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
    Qu CH; Sun QY; Zhang FM; Jia YM
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review on the importance of LINC-ROR in human disorders.
    Ghafouri-Fard S; Pourtavakoli A; Hussen BM; Taheri M; Kiani A
    Pathol Res Pract; 2023 Apr; 244():154420. PubMed ID: 36989849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived exosomal lincRNA ROR promotes angiogenesis in nasopharyngeal carcinoma.
    Zhang S; Cai J; Ji Y; Zhou S; Miao M; Zhu R; Li K; Xue Z; Hu S
    Mol Cell Probes; 2022 Dec; 66():101868. PubMed ID: 36183926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linc-ROR Regulates
    Yu X; Ma X; Jia Y; Wu X; Yan Z
    Cell Transplant; 2023; 32():9636897231178902. PubMed ID: 37306240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of
    Shaalan AAM; Mokhtar SH; Ahmedah HT; Almars AI; Toraih EA; Ibrahiem AT; Fawzy MS; Salem MA
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.